Generics - Financial, South America


Current filters:

FinancialSouth America

Popular Filters

10 billion real to be invested in Brazil’s production of biotech drugs by 2016

10 billion real to be invested in Brazil’s production of biotech drugs by 2016


Brazil's Development Bank (BNDS) plans to invest up to 10 billion real ($4.2 billion) in the production…

BiotechnologyBrazilFinancialGenericsHypermarcasMarkets & MarketingProductionSanofiSouth America

Brazilian pharmachemical sector discussed at parliamentary public hearing


Fiocruz's Production and Innovation in Health vice-president Jorge Bermudez highlighted the importance…

FinancialGenericsProductionSouth America

Brazil interested in investing $4.5 Billion in Ukraine, including pharma


Brazil has submitted to Ukrainian authorities $4.5 billion worth of investment proposals. "We want to…

DiabetesEuropeFinancialGenericsPharmaceuticalProductionSouth America

Venezuelan govt increasing control over pharmaceutical sector


Venezuela's national government has changed its policy with regard to the pharmaceutical sector. This…

FinancialGenericsPharmaceuticalPricingRegulationSouth America

Brazil takes control over its pharma market, but generics threaten to cut future profits


Continuous support from the government is helping the Brazilian pharmaceutical market to expand at a…

FinancialGenericsMarkets & MarketingPharmaceuticalSouth America

Valeant Pharma to acquire assets in Mexico; Mylan invests in Ireland


Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) says it has signed an…

Atlantis PharmaEuropeFinancialGenericsMergers & AcquisitionsMylan LaboratoriesSouth AmericaValeant Pharmaceuticals

Back to top